The fundamental and unsolved problem for Kindler was puny growth and a shortage of new drugs. After a little over four years running the world's largest drug company, Kindler, 55, is retiring.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/12/06/131844019/pfizer-ceo-calls-it-quits?ft=1&f=103537970
Posted
Dec 06 2010, 05:32 AM
by
NPR Blogs: Shots - Health News Blog